logo
episode-header-image
Jun 2021
35m 10s

Alzheimer’s drug has experts divided; ri...

ABC Radio
About this episode
This week, the first of a new series on substance use and what you need to know about ICE - crystal meth. Does early diagnosis of ovarian cancer through screening make a difference to survival rates? And the search for an Alzheimer's disease treatment is as controversial as ever. The US Food and Drug Administration ... Show More
Up next
Jul 2022
4 July: Coming to terms with long COVID; Vaxes for variants; An artificial pancreas; Protecting pandemic teens
Australia has many stories from people who say they have long COVID but who are unable to access help | Updated versions of coronavirus vaccines targeting the Omicron variant have been announced, yet the virus still mutates | People with Type 1 diabetes need to monitor their bloo ... Show More
28m 35s
Jun 2022
Speculating on an Australian Centre of Disease Control and Prevention; How Indigenous culture can protect the heart; Associations between mental health and mortality
What an Australian Centre for Disease Control might aim to be; An Indigenous perspective and research to engage culture for protection against cardiovascular disease and stroke; Research on links between mental health and mortality concludes that both mental and physical health c ... Show More
28m 35s
Jun 2022
Breast density and MRIs, diet and mental health, genomics and osteoarthritis
There may be a link between what you eat and your mental health—also, avoiding overtreatment for breast cancer; predicting your risk of osteoarthritis; and whether mammogram results should inform women about breast density. 
28m 35s
Recommended Episodes
Mar 2023
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ... Show More
13m 46s
Dec 2023
Dementia vs Alzheimer's: Signs, symptoms and preventing Alzheimer's disease with Lisa McGuire, PhD
Following National Alzheimer’s Disease Awareness Month, the CDC shares what physicians and patients need to know about the disease. Lisa McGuire, PhD, lead epidemiologist at the CDC, discusses the importance of catching Alzheimer’s early, its risk factors and barriers to make Alz ... Show More
13m 18s
Aug 2021
Controversial new Alzheimer's drug in the spotlight
After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ... Show More
18m 21s
Aug 2021
Alzheimer’s Dementia
Alzheimer’s disease is a devastating neurodegenerative condition that affects the entire family. As psychiatrists and psychologists, we often support these patients and their families throughout this entire disease process. With the recent and controversial FDA approval of aducan ... Show More
57m 32s
Nov 2022
Why Don’t We Have a Cure for Alzheimer’s? (Ep. 49 Update)
Promising drugs keep failing in trials. Allegations of fraud have cast a shadow over the field. An expert explains why Alzheimer’s treatments have been so hard to find — and why one clue may lie in the Andes Mountains. 
32m 41s
Jun 2021
#164 - Amanda Smith, M.D.: Diagnosing, preventing, and treating Alzheimer’s disease, and what we can all learn from patients with dementia
Amanda Grant Smith is a geriatric psychiatrist with decades of experience treating patients with dementia and Alzheimer's disease. In this episode, Amanda shares how she developed a passion for geriatric psychiatry as a means to support dementia patients. She explains how to reco ... Show More
2h 1m
Aug 2022
49. Why Don’t We Have a Cure for Alzheimer’s?
Promising drugs keep failing in trials. Allegations of fraud have cast a shadow over the field. An expert explains why Alzheimer’s treatments have been so hard to find — and why one clue may lie in the Andes Mountains. 
30m 36s
Jun 2021
FDA Approves Aducanumab — A Controversial Drug For Alzheimer's
The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For ... Show More
11m 52s
Aug 2023
What difference could new Alzheimer’s disease drugs make?
Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ... Show More
28m 37s
Listen to millions of songs and podcasts on Anghami